EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Metabolomic Profiling of Aqueous Humor From Glaucoma Patients Identifies Metabolites With Anti-Inflammatory and Neuroprotective Potential in Mice

Monu Monu, Bhoj Kumar, Rahmat Asfiya, Nariman Nassiri, Vaama Patel, Shibandri Das, Sarah Syeda, Mamta Kanwar, Vivian Rajeswaren, Bret A Hughes, Mark S Juzych, Akhil Srivastava and 2 more

Investigative Ophthalmology & Visual Science · 2025-05-22 · 66 (5) · 28

DOI: 10.1167/iovs.66.5.28 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, published on 2025-05-22. Written by Monu Monu and 13 co-authors. Institution: Department of Ophthalmology, Mason Eye Institute, University of Missouri School of Medicine, Columbia, Missouri, United States. Major MEDLINE topics: Aqueous Humor, Metabolomics, Glaucoma, Open-Angle, Neuroprotective Agents. Cited 10 times so far (Crossref); 46 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NEI NIH HHS, NCATS NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Purpose

Metabolomic profiling of aqueous humor from primary open-angle glaucoma (POAG) patients using targeted metabolomics analysis and assessment of the potential anti-neuroinflammatory and neuroprotective roles of key dysregulated metabolites in a mouse model of retinal neuroinflammation.

Methods

A targeted metabolomics was performed on aqueous humor from POAG patients (n = 19) and healthy subjects (n = 10) via LC-MS/MS. In vitro neuroprotection studies were performed using a mouse cone photoreceptor cell line (661W) exposed to oxidative stress. For in vivo therapeutic studies, a few key dysregulated metabolites were delivered either topically via extracellular vesicle (EV)-mediated delivery or intravitreally into a C57BL/6 mouse model of retinal neuroinflammation. The neuroprotective and anti-neuroinflammatory properties were determined in the presence and absence of metabolites through pattern electroretinography, TUNEL, and quantitative PCR analyses.

Results

Among the 135 endogenous metabolites identified, 31 metabolites showed significant dysregulation in POAG. Metabolite set enrichment analysis revealed that these altered metabolites were associated with dysregulation of multiple key cellular pathways, including glycolysis, pentose phosphate pathway, short-/long-chain fatty acid metabolism, mitochondrial β-oxidation, and electron transport chain under glaucomatous conditions. Among these differentially expressed metabolites, a putative neuromodulator (agmatine) and a vitamin (thiamine) significantly decreased in POAG patients. Intravitreal or EV-mediated topical delivery of agmatine and thiamine significantly reduced the inflammatory response and protected retinal ganglion cell function against neuroinflammatory damage in the mouse retina. Agmatine and thiamine treatment also significantly protected photoreceptor cells from oxidative stress-induced cell death and attenuated the inflammatory cytokine response.

Conclusions

Our results revealed significant metabolic alterations in POAG that affect key cellular functions. Agmatine and thiamine could be potential immunomodulatory or neuroprotective drugs to treat or prevent neuroinflammatory damage to the retina during glaucoma.

Subjects

MeSH terms (MEDLINE)

Aqueous HumorMetabolomicsGlaucoma, Open-AngleNeuroprotective AgentsAnti-Inflammatory AgentsAnimalsMiceMice, Inbred C57BLMaleHumansDisease Models, AnimalFemaleAgedOxidative StressElectroretinographyMiddle AgedChromatography, LiquidTandem Mass SpectrometryRetinal Cone Photoreceptor CellsMetabolomeIn Situ Nick-End Labeling

Substances

Neuroprotective AgentsAnti-Inflammatory Agents

Authors and institutions

  • Department of Ophthalmology, Mason Eye Institute, University of Missouri School of Medicine, Columbia, Missouri, United States.
  • Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia, United States.
  • Department of Pathology and Anatomical Sciences, University of Missouri School of Medicine, Columbia, Missouri, United States.
  • Glaucoma Division, Department of Ophthalmology, UCLA Doheny Eye Institute, Pasadena, California, United States.
  • Department of Ophthalmology, Vanderbilt Eye Institute, Nashville, Tennessee, United States.
  • Department of Ophthalmology, Visual and Anatomical Sciences, Kresge Eye Institute, Wayne State University School of Medicine, Detroit, Michigan, United States.

Funding

  • NEI NIH HHS
  • NCATS NIH HHS

Cite

APA

Monu, M., Kumar, B., Asfiya, R., Nassiri, N., Patel, V., Das, S., Syeda, S., Kanwar, M., Rajeswaren, V., Hughes, B. A., Juzych, M. S., Srivastava, A., Kumar, A., & Singh, P. K. (2025). Metabolomic Profiling of Aqueous Humor From Glaucoma Patients Identifies Metabolites With Anti-Inflammatory and Neuroprotective Potential in Mice. Investigative Ophthalmology & Visual Science, 66(5), 28. https://doi.org/10.1167/iovs.66.5.28

Vancouver

Monu M, Kumar B, Asfiya R, Nassiri N, Patel V, Das S, et al. Metabolomic Profiling of Aqueous Humor From Glaucoma Patients Identifies Metabolites With Anti-Inflammatory and Neuroprotective Potential in Mice. Investigative Ophthalmology & Visual Science. 2025;66(5):28. doi:10.1167/iovs.66.5.28

BibTeX
@article{Monu2025,
  author = {Monu, Monu and Kumar, Bhoj and Asfiya, Rahmat and Nassiri, Nariman and Patel, Vaama and Das, Shibandri and Syeda, Sarah and Kanwar, Mamta and Rajeswaren, Vivian and Hughes, Bret A and Juzych, Mark S and Srivastava, Akhil and Kumar, Ashok and Singh, Pawan Kumar},
  title = {Metabolomic Profiling of Aqueous Humor From Glaucoma Patients Identifies Metabolites With Anti-Inflammatory and Neuroprotective Potential in Mice},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2025},
  volume = {66},
  number = {5},
  pages = {28},
  doi = {10.1167/iovs.66.5.28}
}
Start for free →